Phase IIb trial of ispronicline in adults with attention-deficit hyperactivity disorder.
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2011
At a glance
- Drugs Ispronicline (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 08 Oct 2010 Planned initiation date changed from 1 Jun 2010 to 1 Mar 2011.
- 12 Feb 2010 Initiation is expected in mid 2010, according to a Targacept media release.
- 13 Jul 2009 New trial record.